Haematological Malignancies

10 clinical trials · Condition

Record	Firm	Date
Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies (NCT05148806)	Imperial College London	2021-12-07
Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies (NCT04865419)	AstraZeneca	2021-06-11
Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT) (NCT01827579)	University College, London	2014-07-01
Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT (NCT02988258)	University College, London	2013-07-01
Study of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic Anaemia (NCT01719341)	National University Hospital, Singapore	2012-09-01
CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation (NCT01336478)	Imperial College London	2011-04-01
A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies (NCT01080664)	EMD Serono	2006-12-01

Every clearance here is in the API, with alerts when new ones post.